Stocktoria
ILLUMINA, INC. ILMN
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2000-06-28
ILLUMINA, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $4.3B | $4.4B | $4.5B | $4.6B | $4.5B |
| Gross profit | $2.9B | $2.9B | $2.7B | $3.0B | $3.2B |
| R&D expense | $967.0M | $1.2B | $1.4B | $1.3B | $1.2B |
| SG&A expense | $1.1B | $1.1B | $1.6B | $1.3B | $2.1B |
| Operating income | $807.0M | -$833.0M | -$1.1B | -$4.2B | -$123.0M |
| Interest expense | — | — | $77.0M | $26.0M | $61.0M |
| Income tax | $236.0M | $44.0M | $44.0M | $68.0M | $122.0M |
| Net income | $850.0M | -$1.2B | -$1.2B | -$4.4B | $762.0M |
| EPS (diluted) | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
| Operating cash flow | $1.1B | $837.0M | $478.0M | $392.0M | $545.0M |
| Free cash flow | $931.0M | $709.0M | $283.0M | $106.0M | $337.0M |
| Inventory | $564.0M | $547.0M | $587.0M | $568.0M | $431.0M |
| Total assets | $6.6B | $6.3B | $10.1B | $12.3B | $15.2B |
| Shareholders' equity | $2.7B | $2.4B | $5.7B | $6.6B | $10.7B |
Source: SEC EDGAR filings · CIK 0001110803 · as of 2025-12-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.